259 related articles for article (PubMed ID: 15304374)
21. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
[TBL] [Abstract][Full Text] [Related]
22. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
McMahon M; Marsh HM; Rizza RA
Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
[TBL] [Abstract][Full Text] [Related]
23. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans.
Meyer C; Stumvoll M; Welle S; Woerle HJ; Haymond M; Gerich J
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E819-26. PubMed ID: 12959936
[TBL] [Abstract][Full Text] [Related]
24. [The role of the human kidney for glucose homeostasis].
Buczkowska EO
Wiad Lek; 2004; 57(3-4):158-60. PubMed ID: 15307525
[TBL] [Abstract][Full Text] [Related]
25. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
Basu R; Schwenk WF; Rizza RA
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E55-62. PubMed ID: 14982753
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
27. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans.
Meyer C; Stumvoll M; Dostou J; Welle S; Haymond M; Gerich J
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E428-34. PubMed ID: 11788376
[TBL] [Abstract][Full Text] [Related]
28. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
[TBL] [Abstract][Full Text] [Related]
29. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
30. Pathways for glucose disposal after meal ingestion in humans.
Woerle HJ; Meyer C; Dostou JM; Gosmanov NR; Islam N; Popa E; Wittlin SD; Welle SL; Gerich JE
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E716-25. PubMed ID: 12475753
[TBL] [Abstract][Full Text] [Related]
31. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
32. Sex-related differences in peripheral glucose metabolism in normal subjects.
Paula FJ; Pimenta WP; Saad MJ; Paccola GM; Piccinato CE; Foss MC
Diabete Metab; 1990; 16(3):234-9. PubMed ID: 2210019
[TBL] [Abstract][Full Text] [Related]
33. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia.
Asmann YW; Stump CS; Short KR; Coenen-Schimke JM; Guo Z; Bigelow ML; Nair KS
Diabetes; 2006 Dec; 55(12):3309-19. PubMed ID: 17130474
[TBL] [Abstract][Full Text] [Related]
34. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
35. The role of splanchnic glucose appearance in determining carbohydrate tolerance.
Rizza R
Diabet Med; 1996 Sep; 13(9 Suppl 5):S23-7. PubMed ID: 8894466
[TBL] [Abstract][Full Text] [Related]
36. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
37. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
Abdul-Ghani MA; Matsuda M; DeFronzo RA
Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
[TBL] [Abstract][Full Text] [Related]
38. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
[TBL] [Abstract][Full Text] [Related]
40. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]